Profil
Louise Armstrong-Denby is an Independent Director at CellaVision AB since 2023.
Prior to this, she was the Global Sales Director at Andor Technology Ltd. and the Chief Commercial Officer at Visiopharm A from 2019 to 2023.
She also served as the Chief Sales Officer at Random42 Ltd.
Postes actifs de Louise Armstrong-Denby
| Sociétés | Poste | Début |
|---|---|---|
| CELLAVISION AB | Directeur/Membre du Conseil | 01/01/2023 |
Anciens postes connus de Louise Armstrong-Denby
| Sociétés | Poste | Fin |
|---|---|---|
Visiopharm A/S
Visiopharm A/S Packaged SoftwareTechnology Services Provides AI-driven precision pathology software services for research, diagnostics and biopharmaceutical services | Corporate Officer/Principal | 01/01/2023 |
| ANDOR TECHNOLOGY PLC | Sales & Marketing | - |
Random42 Ltd.
Random42 Ltd. Movies/EntertainmentConsumer Services Provides digital solutions to pharmaceutical and biotech sectors | Sales & Marketing | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
CellaVision AB
CellaVision AB Medical SpecialtiesHealth Technology Manufactures medical instruments | Health Technology |
Andor Technology Ltd.
Andor Technology Ltd. Computer PeripheralsElectronic Technology Develops and manufactures digital cameras and glasses | Electronic Technology |
Visiopharm A/S
Visiopharm A/S Packaged SoftwareTechnology Services Provides AI-driven precision pathology software services for research, diagnostics and biopharmaceutical services | Technology Services |
Random42 Ltd.
Random42 Ltd. Movies/EntertainmentConsumer Services Provides digital solutions to pharmaceutical and biotech sectors | Consumer Services |
















